Skip to main content
JAGU logo

JAGU · Jaguar Uranium Corp. · Short Interest

Track JAGU — free
$1.16 -0.01 (-0.85%) At close · Oct 6
Market Cap
$29.08M
Shares
20.19M
Volume · Oct 6 106.17K Avg daily vol (3M) 124.05K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

JAGU Latest Reported Short Interest

FINRA reported 88,695 JAGU shares sold short as of the September 15, 2026 settlement date, an increase of 3,139 shares. Days to cover was 1.21 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

JAGU Short Interest Forecast

Equibles' model estimates 90,335 shares sold short for the September 30, 2026 settlement, +1.8% versus the latest reported position, with a likely range of 52,021 to 157,666 shares. This model prediction uses FINRA data through September 30, 2026; FINRA's official release is expected October 9, 2026.

Model estimate

Expected Sep 30 short interest

as of Sep 30 Medium confidence 60% chance it rises
90,335 +1.8% vs reported
Likely range 52,021 to 157,666 The latest estimate appears in the chart below. Official release expected Oct 9. Methodology
Short Squeeze Score
42/100
Short interest 0.4% of shares — P32 Days to cover 1.2 — P28 Price vs VWAP -22.6% — P13 Short-volume trend +9.4% — P79 Short interest change +3.7% — P58 Worst FTD 0.05% of shares — P76

Positioning score 42.5 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

No active listed options were found.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-07 06:44 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-10-15 Scheduled
FINRA publishes Oct 26
— — — —
2026-09-30 Scheduled
FINRA publishes Oct 9
— — — —
2026-09-15 88,695 85,556 +3,139 1.21
2026-08-31 85,556 92,859 -7,303 1.00
2026-08-14 92,859 164,325 -71,466 1.44
2026-07-31 164,325 166,967 -2,642 2.35
2026-07-15 166,967 282,965 -115,998 1.78
2026-06-30 282,965 135,816 +147,149 1.39
2026-06-15 135,816 215,236 -79,420 1.21
2026-05-29 215,236 218,919 -3,683 3.20
2026-05-15 218,919 189,246 +29,673 2.26
2026-04-30 189,246 294,351 -105,105 1.00
2026-04-15 294,351 328,723 -34,372 1.07
2026-03-31 328,723 127,896 +200,827 1.00
2026-03-13 127,896 12,630 +115,266 1.00
2026-02-27 12,630 99,178 -86,548 1.00
2026-02-13 99,178 0 +99,178 1.00

Full FINRA short interest reporting calendar

Showing 1–15 of 15 settlements
Key facts CIK 2039273 CUSIP 47010E108 Visit website Investor relations